QualityStocks.net News – Pressure BioSciences, Inc. (PBIO) – Dutton Associates Maintains “Speculative Buy” Rating and $10.00 Price Target - 12/19/07

At www.QualityStocks.Net you can sign up for Quality Stock's Daily Newsletter to find out what Small-Cap and Micro-Cap online Investment Newsletters are interested in, plus hear about the latest news from our clients.

Pressure BioSciences, Inc. (NASDAQ: PBIO) is one of our highlighted companies this month. The company is focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.

In our client’s recent news,

Dutton Associates announced that it has updated its coverage of Pressure BioSciences and that it is reiterating its “Strong Speculative Buy” Rating and $10.00 Price Target. Dutton’s Senior Analyst, Mr. Denise T. Resnik, M.S., completed the 17-page report.

The research firm stated, “We are reiterating our rating of Pressure BioSciences Inc. as a Strong Speculative Buy and our 12-month price target of $10.00 per share. The Company has developed a unique and superior technology for the preparation of biological laboratory samples and is in the early stages of commercialization of its product platform. We expect that the shares will begin to reflect the substantial profits that we believe the Company can generate beginning in 2010.”

“We believe that as the coming 12-month period progresses, Pressure BioSciences will begin to demonstrate its ability to place a rapidly-increasing number of Barocyclers, and that the potential for substantial profits beginning in 2010 will begin to be recognized in these shares. Accordingly, we have established a 12-month price target of $10. Based on a 20 multiple of projected 2010 earnings per share of $1.51, a substantially higher 12-month target stock price could be generated even if this future value is discounted at a rate that reflects the risks to our projections," the firm concluded.

About QualityStocks:

QualityStocks.net, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks.net is dedicated to assisting emerging public companies with their advertising efforts and now has over 400,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

The Quality Stocks Daily Video in High Definition http://Video.QualityStocks.net

The Quality Stocks Daily Blogs http://Blog.QualityStocks.net

The Quality Stocks Daily Message Boards http://MessageBoards.QualityStocks.net

“Please see the disclaimer on our QualityStocks.net website”